Comparing the results from a Swedish pregnancy cohort using data from three automated placental growth factor immunoassay platforms intended for first‐trimester preeclampsia prediction

Author:

Carlsson Ylva12ORCID,Sandström Anna34ORCID,Bergman Lina15,Conner Peter46,Hansson Stefan7,Kublickas Marius8,Görmüş Uzay9,Lindgren Peter8,Oleröd Göran10,Wikström Anna‐Karin11,Larsson Anders12

Affiliation:

1. Department of Obstetrics and Gynecology, Region Västra Götaland Sahlgrenska University Hospital Gothenburg Sweden

2. Center of Perinatal Medicine and Health Institute of Clinical Sciences, University of Gothenburg Gothenburg Sweden

3. Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institute Stockholm Sweden

4. Department of Women's Health, Division of Obstetrics Karolinska University Hospital Stockholm Sweden

5. Department of Obstetrics and Gynecology Institute of Clinical Sciences, University of Gothenburg Gothenburg Sweden

6. Department of Women's and Children's Health Karolinska Institute and Center for Fetal Medicine, Karolinska University Hospital Stockholm Sweden

7. Department of Clinical Sciences Lund, Obstetrics and Gynecology Lund University and Skåne University Hospital Lund/Malmö Sweden

8. Department of Clinical Science, Intervention and Technology – CLINTEC Karolinska Institutet and Center for Fetal Medicine, Karolinska University Hospital Stockholm Sweden

9. PerkinElmer Genomics Stockholm Sweden

10. Department of Clinical Chemistry Sahlgrenska University Hospital Gothenburg Sweden

11. Department of Women's and Children's Health Uppsala University Uppsala Sweden

12. Department of Medical Sciences, Clinical Chemistry Uppsala University Uppsala Sweden

Abstract

AbstractIntroductionRisk evaluation for preeclampsia in early pregnancy allows identification of women at high risk. Prediction models for preeclampsia often include circulating concentrations of placental growth factor (PlGF); however, the models are usually limited to a specific PlGF method of analysis. The aim of this study was to compare three different PlGF methods of analysis in a Swedish cohort to assess their convergent validity and appropriateness for use in preeclampsia risk prediction models in the first trimester of pregnancy.Material and methodsFirst‐trimester blood samples were collected in gestational week 11+0 to 13+6 from 150 pregnant women at Uppsala University Hospital during November 2018 until November 2020. These samples were analyzed using the different PlGF methods from Perkin Elmer, Roche Diagnostics, and Thermo Fisher Scientific.ResultsThere were strong correlations between the PlGF results obtained with the three methods, but the slopes of the correlations clearly differed from 1.0: PlGFPerkinElmer = 0.553 (95% confidence interval [CI] 0.518–0.588) * PlGFRoche –1.112 (95% CI −2.773 to 0.550); r = 0.966, mean difference −24.6 (95% CI −26.4 to −22.8). PlGFPerkinElmer = 0.673 (95% CI 0.618–0.729) * PlGFThermoFisher –0.199 (95% CI −2.292 to 1.894); r = 0.945, mean difference −13.8 (95% CI −15.1 to −12.6). PlGFRoche = 1.809 (95% CI 1.694–1.923) * PlGFPerkinElmer +2.010 (95% CI −0.877 to 4.897); r = 0.966, mean difference 24.6 (95% CI 22.8–26.4). PlGFRoche = 1.237 (95% CI 1.113–1.361) * PlGFThermoFisher +0.840 (95% CI −3.684 to 5.363); r = 0.937, mean difference 10.8 (95% CI 9.4–12.1). PlGFThermoFisher = 1.485 (95% CI 1.363–1.607) * PlGFPerkinElmer +0.296 (95% CI −2.784 to 3.375); r = 0.945, mean difference 13.8 (95% CI 12.6–15.1). PlGFThermoFisher = 0.808 (95% CI 0.726–0.891) * PlGFRoche –0.679 (95% CI −4.456 to 3.099); r = 0.937, mean difference −10.8 (95% CI −12.1 to −9.4).ConclusionThe three PlGF methods have different calibrations. This is most likely due to the lack of an internationally accepted reference material for PlGF. Despite different calibrations, the Deming regression analysis indicated good agreement between the three methods, which suggests that results from one method may be converted to the others and hence used in first‐trimester prediction models for preeclampsia.

Funder

Stiftelsen Handlanden Hjalmar Svenssons

Stiftelserna Wilhelm och Martina Lundgrens

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Reference26 articles.

1. Pre-eclampsia

2. Pre-eclampsia

3. Mödradöd i Sverige: Vården hade många gånger kunnat vara bättre ‐ Lärdomar från 11 års extern kollegial granskning. [Maternal deaths in Sweden: diagnostics and clinical management could be improved];Grunewald C;Lakartidningen,2019

4. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3